<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>The Mesothelioma</title>
	<atom:link href="http://www.the-mesothelioma.net/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.the-mesothelioma.net</link>
	<description></description>
	<lastBuildDate>Tue, 07 Feb 2012 00:03:26 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.2.1</generator>
		<item>
		<title>Vaginal Lawsuit Statement</title>
		<link>http://www.the-mesothelioma.net/vaginal-lawsuit-statement-2/</link>
		<comments>http://www.the-mesothelioma.net/vaginal-lawsuit-statement-2/#comments</comments>
		<pubDate>Tue, 07 Feb 2012 00:03:26 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[The Mesothelioma]]></category>
		<category><![CDATA[Vaginal Lawsuit]]></category>

		<guid isPermaLink="false">http://www.the-mesothelioma.net/?p=502</guid>
		<description><![CDATA[Vaginal Lawsuit : Incontinent nulliparous women have been shown to have a quantitative and qualitative reduction in the collagen content of their tissues12where no evidence of neuromuscular damage exists. In the Nuns Study, 50% postmenopausal) nuns complained of UI; 30% of these complained of stress incontinence, 24% had urge incontinence and 35% had mixed symptoms. [...]]]></description>
			<content:encoded><![CDATA[<p><a title="Vaginal Lawsuit" href="http://www.vaginalmeshlawsuit.redleader.org/mesh"><strong>Vaginal Lawsuit </strong></a>:  Incontinent nulliparous women have been shown to have a quantitative and qualitative reduction in the collagen content of their tissues<sup>12</sup>where no evidence of neuromuscular damage exists. In the Nuns Study, 50%  postmenopausal) nuns complained of UI; 30% of these complained of stress incontinence, 24% had urge incontinence and 35% had mixed symptoms. Therefore, in the absence of obstetric trauma, UI is more commonly seen to be of a stress rather than an urge type It is possible that neuromuscular damage and connective tissue deficiency are co-contributors in the aetiology of UI. Among primigravid women, those with excessive bladder-neck mobility have the highest risk of postpartum urinary incontinence.<sup>14</sup> It seems likeLy that connective tissue damage is a &#8216;prerequisite&#8217;, and that neuromuscular damage contributes to the aetiology of USI.</p>
<p>Thirty-seven percent of women notice a deterioration in symptoms prior to menstruation.<sup>15</sup> Furthermore, progestogens have been associated with an increase in irritative bladder symptoms<sup>1617</sup> and urinary incontinence in those women taking combined hormone replacement therapy.<sup>18</sup> The incidence of DO in the luteal phase of the menstrual cycle may be associated with raised plasma progesterone following ovulation &#8211; progesterone has been shown to antagonize the inhibitory effect of oestradiol on rat detrusor contractions.<sup>19</sup> This may help to explain the increased prevalence of DO found in pregnancy.</p>
<p>For more information on <strong>Vaginal Lawsuit</strong> follow us on our RSS Feeds.</p>
<p>Intervention may be preventive. Elective caesarean section may prevent neuromuscular damage<sup>9</sup> but may not prevent postnatal UI.<sup>4</sup> Rather, antenatal pelvic-floor-muscle training is effective in reducing the incidence of post­partum UI.<sup>8</sup>Postpartum pelvic-floor-muscle training is effective in reducing the incidence of UI at one year. Follow-up of a cohort of women who delivered in 1994 showed that 31.8% of those dry pre­pregnancy are now incontinent.<sup>21</sup> Women with increased bladder-neck mobility have an increased incidence of stress incontinence at 14 weeks postpartum, even if there is no pre­existing symptomatology.<sup>14</sup> However, onset of UI prior to the initial pregnancy is the best predictor of incontinence 5-7 years later.<sup>21</sup> Caesarean section remains protective, but less so than at three months postpartum, with a relatively greater effect with increasing parity. The effect is particularly pronounced if the caesarean section is undertaken prelabour.</p>
<p>Information from other sources on <strong>Vaginal Lawsuit</strong></p>
<p>&#8216;Routine&#8217; episiotomy was introduced in the UK in the 18th Century and has been advocated to prevent severe perineal tears and preserve sexual function. Review of five randomized controlled trials of the use of routine and selective episiotomy reveals that sexual function is poorer in the routine group, with no difference in the prevalence of UI and no difference in pelvic-floor-muscle strength.<sup>24</sup> Ventouse delivery is less traumatic than forceps, but its use has not been shown to be associated with a reduced incidence of UI or neuromuscular damage.</p>
<p>Symptoms of urogenital atrophy are a manifestation of oestrogen withdrawal following the menopause, and may appear many years after the last menstrual period.<sup>1</sup> Oestrogen deficiency following the menopause is known to cause atrophic changes within the urogenital tract<sup>2</sup>and is associated with urinary symptoms. The role of oestrogen replacement in the treatment of these symptoms of urogenital atrophy has still not been clearly defined despite several randomized trials and widespread clinical use. This chapter presents an overview of the pathogenesis and management of urogenital symptoms and the role of oestrogen replacement therapy.</p>
<p>In addition to oestrogen receptors, both androgen and progesterone receptors are expressed in the lower urinary tract, although their role is Less clear. Progesterone receptors are expressed inconsistently, having been reported in the bladder, trigone and vagina. Their presence may be dependent on oestrogen status. In addition, whilst androgen receptors are present in both the bladder and urethra, their role has not yet been defined.</p>
<p>Our use of the term or terms <strong>Vaginal Lawsuit</strong> is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.</p>
<p>To keep up to date on <strong>Vaginal Lawsuit</strong> visit our site often.</p>
<p><strong>Vaginal Lawsuit</strong></p>
]]></content:encoded>
			<wfw:commentRss>http://www.the-mesothelioma.net/vaginal-lawsuit-statement-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Actos Lawyer Data</title>
		<link>http://www.the-mesothelioma.net/actos-lawyer-data/</link>
		<comments>http://www.the-mesothelioma.net/actos-lawyer-data/#comments</comments>
		<pubDate>Fri, 03 Feb 2012 00:40:24 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[The Mesothelioma]]></category>
		<category><![CDATA[Actos Lawyer]]></category>

		<guid isPermaLink="false">http://www.the-mesothelioma.net/?p=499</guid>
		<description><![CDATA[Actos Lawyer: Approximately twenty percent of patients with bladder cancer will complain of irritative voiding symptoms. These symptoms include urinary urgency (a need to rush to the bathroom), burning and urinary frequency. These same symptoms are present in other urologic conditions such as infection, bladder instability and prostatic enlargement in men. These symptoms are most [...]]]></description>
			<content:encoded><![CDATA[<p><strong>Actos Lawyer</strong>:  Approximately twenty percent of patients with bladder cancer will complain of irritative voiding symptoms. These symptoms include urinary urgency (a need to rush to the bathroom), burning and urinary frequency. These same symptoms are present in other urologic conditions such as infection, bladder instability and prostatic enlargement in men. These symptoms are most commonly associated with a diffuse superficial form of transitional cell cancer of the bladder called CIS (carcinoma in situ). Unfortunately for some, their diagnosis may be delayed since these symptoms are present in so many other diseases.</p>
<p>Cystoscopy (examination of the bladder) is usually the first step in making the diagnosis of bladder cancer. Given the signs and symptoms suggesting bladder cancer, or an X ray or ultrasound revealing a possible bladder tumor, cystoscopy is a must. Cystoscopy can be accomplished with either a flexible cystoscope or a rigid scope. The flexible cystoscope is composed of small optical fibers encased by a plastic sheath. A rigid scope has glass lenses within a metal sheath. Both cystoscopes are passed directly through the urethra into the bladder to visualize the inside surface. Cystoscopy can be accomplished in both the urologist’s office or as an outpatient at a hospital or surgicenter.</p>
<p>For more information on <strong>Actos Lawyer</strong> follow us on our RSS Feeds.</p>
<p>The flexible cystoscope is easier and less painful to pass, especially for males whose urethra is longer and more tortuous than in females. Flexible cystoscopy is readily accomplished in the doctor’s office. A lubricant is applied to the scope to ease passage. Local anesthesia can be squirted into the urethra prior to passing the scope. Discomfort from the cystoscope is usually well tolerated and short in duration. The discomfort usually lasts a few seconds as the scope is passed through the prostate. At that time, you may feel a pressure sensation. In females, passage of the scope is quick and relatively painless.</p>
<p>During the exam, your bladder will be filled with sterile water to allow complete visualization of all the surfaces. You may feel like you have to urinate. During flexible cystoscopy, small biopsies can be obtained. Any bleeding from the biopsy site is readily controlled. The biopsy and cauterization will cause pain for a few seconds. A mild oral sedative can be taken prior to an exam, but is generally not necessary. An entire examination may take only a few minutes. If biopsies are done, the exam will be a little longer. Flexible cystoscopy is very convenient. You can drive yourself to and from the office. After the exam, you can generally go right back to work. If a tumor is found that is too large to treat with a flexible cystoscope, you will be scheduled for an additional procedure at a hospital or surgicenter.</p>
<p>Information from other sources on <strong>Actos Lawyer</strong></p>
<p>The rigid cystoscope, although easy to pass in a female is difficult to pass without sedation in a male. The rigid cystoscope allows for generous biopsy specimens and removal of small tumors. Cystoscopy therefore can provide for both diagnosis and treatment at the same time. If a large cancer is found, removal with a resectoscope can be used to remove it at the same time. If multiple biopsies or resection of a cancer is done, spinal or general anesthesia may be required. Since rigid cystoscopy generally causes more discomfort than flexible cystoscopy and requires more anesthetic, you can expect to be out of work at least one day. In addition, someone will need to drive you home from the surgicenter or hospital.</p>
<p>If you are being initially screened for asymptomatic microscopic hematuria, a urologist will often choose flexible cystoscopy as the first step. He is not certain whether or not you have a bladder cancer or other condition causing the hematuria. Flexible cystoscopy will provide that answer in a less time consuming, less painful and more cost effective way than rigid cystoscopy. On the other hand, if there is a high likelihood a tumor is present, it makes sense to do rigid cystoscopy and if required, resection all at one setting. If you are experiencing gross hematuria, flexible cystoscopy does not provide adequate visualization, and rigid cystoscopy is warranted. Many urologists use both types of cystoscopes, but some do not have the flexible cystoscope in their office.</p>
<p>Our use of the term or terms <strong>Actos Lawyer</strong> is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.</p>
<p>To keep up to date on <strong>Actos Lawyer</strong> visit our site often.</p>
<p><strong>Actos Lawyer</strong></p>
]]></content:encoded>
			<wfw:commentRss>http://www.the-mesothelioma.net/actos-lawyer-data/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Trans Vaginal Mesh Lawsuit</title>
		<link>http://www.the-mesothelioma.net/trans-vaginal-mesh-lawsuit/</link>
		<comments>http://www.the-mesothelioma.net/trans-vaginal-mesh-lawsuit/#comments</comments>
		<pubDate>Thu, 02 Feb 2012 00:08:05 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[The Mesothelioma]]></category>
		<category><![CDATA[Trans Vaginal Mesh Lawsuit]]></category>

		<guid isPermaLink="false">http://www.the-mesothelioma.net/?p=497</guid>
		<description><![CDATA[Trans Vaginal Mesh Lawsuit : The frequency-voLume (FV) chart (Figure 3.1) is an important tool in the investigation of patients with lower urinary tract symptoms and voiding dysfunction.10 The chart is variously known as a FV chart, bladder diary or voiding diary, and is completed daily by the patient over a number of days prior [...]]]></description>
			<content:encoded><![CDATA[<p><a title="Vaginal Lawsuit" href="http://www.vaginalmeshlawsuit.redleader.org/mesh"><strong>Trans Vaginal Mesh Lawsuit</strong></a> :  The frequency-voLume (FV) chart (Figure 3.1) is an important tool in the investigation of patients with lower urinary tract symptoms and voiding dysfunction.<sup>10</sup> The chart is variously known as a FV chart, bladder diary or voiding diary, and is completed daily by the patient over a number of days prior to the visit to the doctor. This facilitates history taking regarding the degree of frequency, nocturia and volumes voided at each episode. Compulsive or excessive fluid consumption, normal consumption at inappropriate times (eg bedtime), or an excessive intake of alcohol or caffeine is easily identified and behavioural modification can be commenced.</p>
<p>The pad test is a simple, reliable, non-invasive test that quantifies loss by recording the weight change of the pad after it has been worn by the patient under investigation. More than 10 protocols have been described, which vary according to time and bladder filling. The original evaluation of a one-hour pad test was published in 1981<sup>13</sup> and found that pad- weight change of more than 1 g shouLd be regarded as abnormal and worthy of further investigation. In another study comparing continent and incontinent women, the 99% upper confidence limit for urine loss was 1.4 g in continent women with normal urodynamics.<sup>1</sup>&#8216;<sup>1</sup> The ICS has set the upper limit of normal for a one-hour pad test as 2 g.<sup>15</sup> The ICS standardized pad test<sup>16</sup> consists of drinking 500 ml of sodium-free liquid within a 15- minute time frame. A pre-weighed perineal pad is placed into the individual&#8217;s underwear, following which a series of set manoeuvres are carried out,.</p>
<p>For more information on <strong>Trans Vaginal Mesh Lawsuit</strong> follow us on our RSS Feeds.</p>
<p>only 2% of women sit directly on the seat in public toilets, whereas 85% crouch above the seat.<sup>21</sup>Approximately 38% of respondents crouch above the seat even in their friends&#8217; toilets! The same study demonstrated a 21% reduction in mean flow rate and 149% increase in residual volume in the crouching position. It is therefore essential that uroflowmetry be undertaken in private, preferably behind a locked door, and women should be specifically instructed to sit for the test. When considering surgical treatment of UI it is important to be clear about the underlying cause. Whereas USI is often successfully treated by surgical intervention, DO is not. Indeed it may be made worse by incontinence surgery.</p>
<div>
<p>The technique of cystometry is well established. A filling catheter and fluid-filled pressure transducer are inserted into the bladder via the urethra. A fluid-filled pressure transducer is then inserted into the rectum via the anus or the vagina. Subtraction of the intraabdominal pressure from the intravesical pressure (subtraction cystometry) allows assessment of the relationship between pressure and volume during filling and of detrusor function. Video-urodynamics combines fluoroscopic imaging of the bladder neck with cystometry by filling the bladder with iodine-based contrast medium. This allows differentiation between USI due to bladder neck hypermobility and that due to ISD. In addition, anatomical variants can be identified.</p>
</div>
<p>Information from other sources on <strong>Trans Vaginal Mesh Lawsuit</strong></p>
<p>This is especially common in women with neurogenic bladder probLems. It is therefore important to be aware of any abnormalities in the renal tract, and the presence of vesico-ureteric reflux. This may be visualized by radiological screening during cystometry in either the filling or voiding phase. Patients with spinal cord injury commonly suffer with lower urinary tract symptoms. Video-urodynamics is especially useful to detect detrusor-sphincter dyssynergia, where voiding difficulties are caused by failure of the urethral sphincter to relax at the same time as the detrusor muscle contracts.</p>
<p>Our use of the term or terms <strong>Trans Vaginal Mesh Lawsuit</strong> is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.</p>
<p>To keep up to date on <strong>Trans Vaginal Mesh Lawsuit</strong> visit our site often.</p>
<p><strong>Trans Vaginal Mesh Lawsuit</strong></p>
]]></content:encoded>
			<wfw:commentRss>http://www.the-mesothelioma.net/trans-vaginal-mesh-lawsuit/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Vaginal Lawsuit Statement</title>
		<link>http://www.the-mesothelioma.net/vaginal-lawsuit-statement/</link>
		<comments>http://www.the-mesothelioma.net/vaginal-lawsuit-statement/#comments</comments>
		<pubDate>Wed, 01 Feb 2012 23:52:22 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[The Mesothelioma]]></category>
		<category><![CDATA[Vaginal Lawsuit]]></category>

		<guid isPermaLink="false">http://www.the-mesothelioma.net/?p=495</guid>
		<description><![CDATA[Vaginal Lawsuit : Incontinent nulliparous women have been shown to have a quantitative and qualitative reduction in the collagen content of their tissues12where no evidence of neuromuscular damage exists. In the Nuns Study, 50% postmenopausal) nuns complained of UI; 30% of these complained of stress incontinence, 24% had urge incontinence and 35% had mixed symptoms. [...]]]></description>
			<content:encoded><![CDATA[<p><a title="Vaginal Lawsuit" href="http://www.vaginalmeshlawsuit.redleader.org/mesh"><strong>Vaginal Lawsuit </strong></a>:  Incontinent nulliparous women have been shown to have a quantitative and qualitative reduction in the collagen content of their tissues<sup>12</sup>where no evidence of neuromuscular damage exists. In the Nuns Study, 50%  postmenopausal) nuns complained of UI; 30% of these complained of stress incontinence, 24% had urge incontinence and 35% had mixed symptoms. Therefore, in the absence of obstetric trauma, UI is more commonly seen to be of a stress rather than an urge type It is possible that neuromuscular damage and connective tissue deficiency are co-contributors in the aetiology of UI. Among primigravid women, those with excessive bladder-neck mobility have the highest risk of postpartum urinary incontinence.<sup>14</sup> It seems likeLy that connective tissue damage is a &#8216;prerequisite&#8217;, and that neuromuscular damage contributes to the aetiology of USI.</p>
<p>Thirty-seven percent of women notice a deterioration in symptoms prior to menstruation.<sup>15</sup> Furthermore, progestogens have been associated with an increase in irritative bladder symptoms<sup>1617</sup> and urinary incontinence in those women taking combined hormone replacement therapy.<sup>18</sup> The incidence of DO in the luteal phase of the menstrual cycle may be associated with raised plasma progesterone following ovulation &#8211; progesterone has been shown to antagonize the inhibitory effect of oestradiol on rat detrusor contractions.<sup>19</sup> This may help to explain the increased prevalence of DO found in pregnancy.</p>
<p>For more information on <strong>Vaginal Lawsuit</strong> follow us on our RSS Feeds.</p>
<p>Intervention may be preventive. Elective caesarean section may prevent neuromuscular damage<sup>9</sup> but may not prevent postnatal UI.<sup>4</sup> Rather, antenatal pelvic-floor-muscle training is effective in reducing the incidence of post­partum UI.<sup>8</sup>Postpartum pelvic-floor-muscle training is effective in reducing the incidence of UI at one year. Follow-up of a cohort of women who delivered in 1994 showed that 31.8% of those dry pre­pregnancy are now incontinent.<sup>21</sup> Women with increased bladder-neck mobility have an increased incidence of stress incontinence at 14 weeks postpartum, even if there is no pre­existing symptomatology.<sup>14</sup> However, onset of UI prior to the initial pregnancy is the best predictor of incontinence 5-7 years later.<sup>21</sup> Caesarean section remains protective, but less so than at three months postpartum, with a relatively greater effect with increasing parity. The effect is particularly pronounced if the caesarean section is undertaken prelabour.</p>
<p>Information from other sources on <strong>Vaginal Lawsuit</strong></p>
<p>&#8216;Routine&#8217; episiotomy was introduced in the UK in the 18th Century and has been advocated to prevent severe perineal tears and preserve sexual function. Review of five randomized controlled trials of the use of routine and selective episiotomy reveals that sexual function is poorer in the routine group, with no difference in the prevalence of UI and no difference in pelvic-floor-muscle strength.<sup>24</sup> Ventouse delivery is less traumatic than forceps, but its use has not been shown to be associated with a reduced incidence of UI or neuromuscular damage.</p>
<p>Symptoms of urogenital atrophy are a manifestation of oestrogen withdrawal following the menopause, and may appear many years after the last menstrual period.<sup>1</sup> Oestrogen deficiency following the menopause is known to cause atrophic changes within the urogenital tract<sup>2</sup>and is associated with urinary symptoms. The role of oestrogen replacement in the treatment of these symptoms of urogenital atrophy has still not been clearly defined despite several randomized trials and widespread clinical use. This chapter presents an overview of the pathogenesis and management of urogenital symptoms and the role of oestrogen replacement therapy.</p>
<p>In addition to oestrogen receptors, both androgen and progesterone receptors are expressed in the lower urinary tract, although their role is Less clear. Progesterone receptors are expressed inconsistently, having been reported in the bladder, trigone and vagina. Their presence may be dependent on oestrogen status. In addition, whilst androgen receptors are present in both the bladder and urethra, their role has not yet been defined.</p>
<p>Our use of the term or terms <strong>Vaginal Lawsuit</strong> is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.</p>
<p>To keep up to date on <strong>Vaginal Lawsuit</strong> visit our site often.</p>
<p><strong>Vaginal Lawsuit</strong></p>
]]></content:encoded>
			<wfw:commentRss>http://www.the-mesothelioma.net/vaginal-lawsuit-statement/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Cell Phone Privacy Lawsuit Information</title>
		<link>http://www.the-mesothelioma.net/cell-phone-privacy-lawsuit-information/</link>
		<comments>http://www.the-mesothelioma.net/cell-phone-privacy-lawsuit-information/#comments</comments>
		<pubDate>Thu, 26 Jan 2012 19:22:26 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[The Mesothelioma]]></category>
		<category><![CDATA[Cell Phone Privacy Lawsuit]]></category>

		<guid isPermaLink="false">http://www.the-mesothelioma.net/?p=493</guid>
		<description><![CDATA[Cell Phone Privacy Lawsuit News- 1/25/2012: Increasingly, cell phone calls and computer communications, whether over personal computer, laptop, or handheld device with multiple functionality, are being transmitted over the Internet in a wireless form, giving users greater mobility and allowing them to work, socialize, and interact with others anyplace where there is wireless service available. [...]]]></description>
			<content:encoded><![CDATA[<p><a title="Cell Phone Privacy Lawsuit" href="http://www.cellphoneprivacylawsuit.com"><strong>Cell Phone Privacy Lawsuit</strong></a> <strong>News</strong>- 1/25/2012: Increasingly, cell phone calls and computer communications, whether over personal computer, laptop, or handheld device with multiple functionality, are being transmitted over the Internet in a wireless form, giving users greater mobility and allowing them to work, socialize, and interact with others anyplace where there is wireless service available. Work is no longer confined to the office, playing games can take place alone or with anonymous participants in cyberspace, and daily life can incorporate multiple functions from different locations. For many, the typical nine-to-five workday is becoming a distant memory, and the types of activities formerly associated with &#8220;home,” &#8220;work,” and &#8220;leisure” are no longer clearly separated. There is some irony in thinking that using cell phones and the Internet gives us more flexibility about where we go and how we control our time, but at the same time, many people report that they feel more stress in their lives, rather than less. Could these two technologies be contributing to more stress, rather than simplifying or facilitating our lives?</p>
<p>Everyone has a strong opinion about cell phones. Many people complain that the cell phone is an annoyance, but then claim they couldn’t live without one. The cell phone is not just a more portable version of our traditional wired telephone. It is a small, portable technology that allows us to make phone calls and participate in a wide range of media interactions anywhere, anytime (as long as we’re in range of a cell tower). It is actually remarkable that in a period of about ten years, cell phones have become a &#8220;must-have” technology for many, despite the often-poor reception quality or unreliability of cell phones, the need to remember to charge them, and their extra cost. In the United States, where 92.9 percent of the population already has access to a telephone,<sup>1</sup> the growth of the less reliable and more expensive cell phone is nothing short of a phenomenon.</p>
<p>The Internet became a viable form of communication as early as the 1960s, but the commercial explosion of home-based Internet use started in the early 1990s. Like many technologies that seem to become second nature to a segment of the population, the Internet has developed to provide a host ofservices that may have been already available to people in other ways before they found their way to the online world. Many people, particularly the younger members of our society, spend hours each day negotiating the world of the Internet—time they are not spending with other forms of media or with other people. Google’s acquisition of the popular Internet site YouTube, on which anyone can post video clips, made headlines in October 2006 because of the $1.65 billion (in stock) purchase price. Within two months, Verizon, Fox, CBS, and NBC announced that they, too, were collaborating on offering an Internet alternative to YouTube.<sup>5</sup> The television and film industries know that they’ve got to court the Internet crowd or lose valuable viewers of traditional media content.</p>
<p>For more information on <strong>Cell Phone Privacy Lawsuit</strong>: follow us on our RSS Feeds.</p>
<p>Personal habits also condition people to use communication technologies in particular ways. Checking cell phone messages or answering e-mail first thing in the morning is now as much of a routine for many as having a cup of coffee or brushing your teeth. Getting news or music over the Internet is convenient and can be done while sending e-mail, reading the latest celebrity gossip, or working from home, all over the Internet. Who your &#8220;friends” are can be listed in an available directory on a cell phone or on any number of personal social networking sites on the Internet. When a cell phone is programmed to block calls from anyone who hasn’t been entered into an &#8220;approved” call list, or someone removes your name from their roster of &#8220;friends,” the number of interactions on either technology are limited. There is no surprise that many people claim that the more we have access to communication technologies, the less we really communicate.</p>
<p>Sometimes cell phones and the Internet are the catalysts for social change, and sometimes they reflect social change: either way, these technologies are contributing to subtle changes in American values and to how different groups (based on age, gender, class, and race) use those changes to define individual and group identities. This book is about the changes that cell phones and the Internet—the dynamic duo—are bringing to American life, where the technologies always seem to be &#8220;on.” As a cultural history, this book examines how these two technologies—separately and together—are contributing to a change in American attitudes, behaviors, and cultural values.</p>
<p>It is probably human nature to want to believe that all technologies make our lives easier, better, or more efficient. After all, commercials for these products and services promise us better control over the chaos of our lives. When we first start using a new technology, we experience a learning curve. For those who learn quickly, expectations for what the technology can do for us can be wonderful. Those who struggle to learn how to use the technology may experience greater stress or anxiety. Some people try something, only to realize that they don’t really like or need it. But those who do master the technology tend not to notice how they begin to rely on it. The instantaneous nature of communicating with cell phones and the Internet leads us to transmit and receive information faster and with less consideration for how it might affect our lives. Our ability to connect immediately, anywhere, anytime, to someone conditions us to think of all activities in full operation twenty-four hours a day, seven days a week. That hum we feel in the air may be constant, invisible potential for immediacy—or it may well be anxiety, particularly for those who allow these technologies to infiltrate so many aspects of daily life. Or, it may accompany the unspoken reality that our daily activities, both private and public, are changing our culture in ways that we don’t yet truly understand, and for that reason, we feel uncomfortable.</p>
<p>Information from other sources on <strong>Cell Phone Privacy Lawsuit</strong>:</p>
<p>Earlier technologies give us a clue to understanding social change. The telegraph and telephone changed American culture; they united east and west coasts with a distribution form that delivered communication and messages to people and changed the way they lived, worked, and played. The wired model of communi­cation became the backbone for telephony and the Internet, and even though we increasingly use these technologies in wireless form, the institutions, practices, and social attitudes about communication remain rooted in the structures that intro­duced wired communications to American culture in the late nineteenth century and all of the twentieth.</p>
<p>Our use of the term or terms <strong>Cell Phone Privacy Lawsuit</strong>: is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.</p>
<p>To keep up to date on <strong>Cell Phone Privacy Lawsuit</strong>: visit our site often.</p>
<p><strong>Cell Phone Privacy Lawsuit</strong></p>
]]></content:encoded>
			<wfw:commentRss>http://www.the-mesothelioma.net/cell-phone-privacy-lawsuit-information/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Mesothelioma Cancer Data</title>
		<link>http://www.the-mesothelioma.net/mesothelioma-cancer-data/</link>
		<comments>http://www.the-mesothelioma.net/mesothelioma-cancer-data/#comments</comments>
		<pubDate>Thu, 26 Jan 2012 18:54:49 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[The Mesothelioma]]></category>
		<category><![CDATA[Mesothelioma Cancer]]></category>

		<guid isPermaLink="false">http://www.the-mesothelioma.net/?p=491</guid>
		<description><![CDATA[Mesothelioma Cancer : The doctor may also request an MRI (magnetic reso­nance image). An MRI uses radio waves and strong magnets along with a computer to form detailed images of the body. The MRI can occasionally give the doctor information about whether the diaphragm or chest wall have become involved and if the tumor has [...]]]></description>
			<content:encoded><![CDATA[<p><a title="Mesothelioma Cancer" href="http://www.mesotheliomacancerwiki.com"><strong>Mesothelioma Cancer</strong> </a>: The doctor may also request an MRI (magnetic reso­nance image). An MRI uses radio waves and strong magnets along with a computer to form detailed images of the body. The MRI can occasionally give the doctor information about whether the diaphragm or chest wall have become involved and if the tumor has invaded through it. Not all mesothelioma specialists use MRIs in their workup. A PET scan (positron emission tomography scan) is a relatively new type of scan that shows how the body takes up and uses glucose (sugar). Tumors, cancer cells, and areas that are inflamed or infected use glucose at a higher rate than normal tissues do. Since a radioactive tracer is attached to the glucose injected into your body, the areas which use glucose at a higher rate (i.e. tumors) will hold onto the radioactive tracer longer than normal cells. Areas on PET scans that &#8220;light up” as bright spots are abnormal. It is important to know, however, that abnormal areas on PET scans are not necessarily cancerous; they can also be the result of inflammation. The PET scan can also give the doctor information as to whether the cancer has spread outside the original area to other parts of the body, and it may pick up areas of spread that are completely unexpected. <a title="Mesothelioma Cancer" href="http://www.mesotheliomacancerwiki.com"><strong>Mesothelioma Cancer</strong></a></p>
<p>For more information on <strong>Mesothelioma Cancer</strong> follow us on our RSS Feeds.</p>
<p>There have not been enough large studies that prove the usefulness of this scan in mesothelioma, and therefore it has not been approved by most insurance companies as a standard test for mesothelioma, as it has been for lung cancer. However, there are mechanisms that can help pay for PET scans that doctors who do them (nuclear medicine physicians) can help you with. Ask them about these programs. A patient with a large, unexplained fluid accumulation in the chest or abdomen and who has a small or moder­ate amount of thickening of the pleura should have a biopsy performed, using semi-invasive techniques (tech­niques that require only local anesthesia and that do not involve cutting into the chest or abdomen). For exam­ple, the biopsy might involve an initial thoracentesis (drainage of fluid in the chest) or paracentesis (drainage of fluid in the abdomen) and a pleural biopsy. These are relatively safe procedures that can be performed by a pulmonologist (lung physician), a radiologist, or a sur­geon. A local anesthetic (a numbing medicine such as lidocaine) is given to temporarily reduce the feeling in the area before the needle is inserted. <a title="Mesothelioma Cancer" href="http://www.mesotheliomacancerwiki.com"><strong>Mesothelioma Cancer</strong></a></p>
<p>Information from other sources on <strong>Mesothelioma Cancer</strong></p>
<p>A pleural biopsy with a special needle may help in get­ting a diagnosis of mesothelioma, and it is generally performed by a pulmonologist. Since mesothelioma is usually diffuse (widely scattered) in the chest, a ran­dom sample of the pleura may give tissue with mesothelioma cells in it. A thoracentesis can be performed after the pleural biopsy is completed. The doctor inserts a needle into the pocket of fluid in the chest or abdomen to draw off some of the fluid. Many times, the needle is simply used to insert a flexible catheter (a tube the size of thin spaghetti) which is then used to draw off the fluid. After the fluid is drawn out through this catheter, the catheter is removed.</p>
<p>Our use of the term or terms <strong>Mesothelioma Cancer</strong> is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.</p>
<p>To keep up to date on <strong>Mesothelioma Cancer</strong> visit our site often.</p>
<p><strong>Mesothelioma Cancer</strong></p>
]]></content:encoded>
			<wfw:commentRss>http://www.the-mesothelioma.net/mesothelioma-cancer-data/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Carrier IQ Lawsuit Breaking News</title>
		<link>http://www.the-mesothelioma.net/carrier-iq-lawsuit-breaking-news/</link>
		<comments>http://www.the-mesothelioma.net/carrier-iq-lawsuit-breaking-news/#comments</comments>
		<pubDate>Thu, 26 Jan 2012 18:23:49 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[The Mesothelioma]]></category>
		<category><![CDATA[Carrier IQ Lawsuit]]></category>

		<guid isPermaLink="false">http://www.the-mesothelioma.net/?p=489</guid>
		<description><![CDATA[Carrier IQ Lawsuit News &#8211; 1/25/2012 : In many countries, governments have discussed and proposed laws to regulate privacy protection and mechanisms to punish people and organizations that break the rules. Until privacy laws are really enforced, however, companies will find few incentives to protect and respect user privacy, mainly because most users don’t even [...]]]></description>
			<content:encoded><![CDATA[<p><a title="Carrier IQ Lawsuit" href="http://www.carrieriqlawsuit.net"><strong>Carrier IQ Lawsuit</strong></a> <strong>News</strong> &#8211; 1/25/2012 : In many countries, governments have discussed and proposed laws to regulate privacy protection and mechanisms to punish people and organizations that break the rules. Until privacy laws are really enforced, however, companies will find few incentives to protect and respect user privacy, mainly because most users don’t even realize that their privacy can be violated. A central problem is that behavior on the Web can’t be controlled. To regulate the Web, governments would have to regulate code writing or how Web applications (browsers, Java, e-mail systems, and so on ) function (Lessig, 1999). Also it is difficult to reach international consensus on Web privacy because the privacy concept is heavily dependent on widely variable cultural and political issues.</p>
<p>Later on U.S. government asked the Commerce Department to work with the Federal Trade Commission (FTC) to encourage organizations to implement self-regulatory practices. An FTC report in 2000, however concluded that U.S. self-regulatory approaches were ineffective in safeguarding consumer information, marketing techniques employed to profile customers were increasingly intrusive, and congressional legislative action was warranted to protect consumer privacy online (Electronic Privacy Information Center. The self-regulatory approach adopted by the U.S. is in direct contrast with the government-mandated approach adopted by the European Union (EU). Under the EU’s 1995, and subsequent 1997, Directive on Data Privacy, the burden is placed on companies and organizations—not individuals—to seek permission before using personal information for any purpose (Consumer International, 2003).</p>
<p>In July 2000, however, the United States negotiated a safe harbor agreement with the EU commission, wherein U.S. companies can voluntarily self-certify to adhere to a set of privacy principles loosely based on the fair information practices developed by the commerce department and the EU Commission. The primary difference under safe harbor is the ability of U.S. companies to administer self-enforcement by the European Commissioner or other agencies for compliance with the explicit rules of the EU directive (Consumer International, 2003). Although the United States recently passed new online privacy legislation, including the Childerns Online Privacy Protection Act (COPPA), Provisions in the Gramm-Leach-Bliley Financial Modernization Act (GLB) and the Health Insurance Portability and Accountability Act (HIPAA), these laws are applicable to relatively narrow types of information and particular industry sectors (Turner &amp; Dasgupta, 2003).</p>
<p>For more information on <strong>Carrier IQ Lawsuit</strong>: follow us on our RSS Feeds.</p>
<p>The issue of who has control over personal data and how this data is used needs to be addressed at a global level in order for the Internet to develop into a trusted, widely acceptable international marketplace for the exchange of goods and services. The primary technology for collecting information on an individual’s activities over the Internet has been the Web &#8220;Cookie.” Cookies are digital information sent from a Web server and stored on the hard drive of an individual’s computer by the browser software or network application. Cookies were designed to address the problem of statelessness inherent in the Hypertext Transfer Protocol (HTTP) (Kristol, 2002). Because a browser does not stay connected to a server, but instead makes a connec­tion, sends its request, downloads the response, and makes a new connection to send another request, it severely limited the functionality ofWeb services and complicated application development. Web cookies provide a solution to this statelessness by allowing for continuity in the interaction between the browser and the Web server. The cookie has proven to be the most reliable, robust, and network friendly means to provide needed state functionality on the Web, although this functionality can also be provided by embedding state information in URLs, using hidden fields in HTML forms, or using the client’s IP address (Kristol, 2002).</p>
<p>Web bugs are hidden images that can be covertly added to any Web page; e-mail, or Microsoft Word, Excel, or PowerPoint file and used to collect information about user bahaviour. Web bugs send messages back to a server indicating its location, including the IP address of the computer, the URL of the page, the time the Web page or document was viewed, the type of browser used, and the previously set cookie value. Web bugs can also be used to determine if and when a Web page, e-mail message, or document is opened, the IP address of the recipient, and how often and to whom information is forwarded and opened (Harding, 2001).</p>
<p>Web bugs can also be used to associate a Web browser cookie to a particular e-mail address and read previously set cookie values. Thus, a source server with a very small or invisible window could be added to any Web site or Web-enabled file and used serendipitously for a variety of tracking, surveillance, and monitoring activities (Berghel, 2001). Monitoring browsing activities in and of itself is not considered by most Web users to be privacy invasive; however it is the ability to then link these activities back to an individual that has most consumers and privacy advocates alarmed (Turner &amp; Dasgupta, 2003).</p>
<p>Information from other sources on <strong>Carrier IQ Lawsuit</strong>:</p>
<p>One of the first technologies available for protecting privacy on the Internet was the anonymizer. Anonymizers provide the ability to sanitize packet headers passed from the client to the server. Early versions consisted of software that would act like a proxy server, intercepting all communication between the browser and the server and removing all information about the requester. Current versions use Se­cure Socket Layers (SSL) technology for sending URL requests, establishing an encrypted communications tunnel between the user and the anonymizer proxy, and routing traffic through a number of proxy servers (Electronic Privacy Information Center, 1999).</p>
<p>This firewall- like technology disguises a user’s IP address, similar to most Internet service providers, and supplies with dynamic IP addresses every time they log on. Software tools are also available that provide a pseudonym proxy for logging on the Web sites, giving users consistent access to registration based systems without revealing personal data (Gabber, 1999).  Web users can also install a filter, such as the one offered by Anonymizer. Filters are software programs that block cookies, banner advertisements and Web bugs. The disadvantage of filters is that they fail to consider consent; they block all cookies and thus users lose access to all personalized services, even those from the most trustworthy of sites. Also filters make privacy invasion difficult, but not impossible. A site can still identify users by IP address, interaction time, and geographical loca­tion, for example.</p>
<p>Given this users might need additional levels of privacy protection (Ishitani, 2003). These tool provide a means to protect the network identity of the computer; however, there are also negative performance and reliability consequen- ses. In addition, some specialized proxy servers can be used to intercept and alter information between client and server (Berghel, 2002). There are other technology-based solutions available for protecting privacy, includ­ing tools for filtering HTML allowing users to block certain URLs, anonymous re-mailers for sending and receiving e-mail messages, and software for managing Web cookies (Electronic Privacy Information Center, 1999).</p>
<p>Our use of the term or terms <strong>Carrier IQ Lawsuit</strong>: is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.</p>
<p>To keep up to date on<strong> Carrier IQ Lawsuit</strong>: visit our site often.</p>
<p><strong>Carrier IQ Lawsuit</strong></p>
]]></content:encoded>
			<wfw:commentRss>http://www.the-mesothelioma.net/carrier-iq-lawsuit-breaking-news/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Mesothelioma Lawyers Information</title>
		<link>http://www.the-mesothelioma.net/mesothelioma-lawyers-information/</link>
		<comments>http://www.the-mesothelioma.net/mesothelioma-lawyers-information/#comments</comments>
		<pubDate>Thu, 26 Jan 2012 17:59:21 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[The Mesothelioma]]></category>
		<category><![CDATA[Mesothelioma Lawyers]]></category>

		<guid isPermaLink="false">http://www.the-mesothelioma.net/?p=487</guid>
		<description><![CDATA[Mesothelioma Lawyers : The fluid and the tissue from the pleural biopsy will be sent to a pathologist and/or cytologist who will look under the microscope at the cells and determine whether mesothelioma is present. In the past, a diag­nosis of mesothelioma from fluid alone was possible only a third of the time because of [...]]]></description>
			<content:encoded><![CDATA[<p><a title="Mesothelioma Lawyers" href="http://www.mesotheliomalawyerswiki.com"><strong>Mesothelioma Lawyers</strong></a> :  The fluid and the tissue from the pleural biopsy will be sent to a pathologist and/or cytologist who will look under the microscope at the cells and determine whether mesothelioma is present. In the past, a diag­nosis of mesothelioma from fluid alone was possible only a third of the time because of the difficulty of distinguishing between reactive or noncancerous cells and tumor cells. By staining the fluid with a special substance, pathologists can now make a diagnosis more easily. Your doctor will refer to these stains as &#8220;immunos,” short for immunohistochemistry. You should make sure that any material used in the biopsy has been studied using these immuno stains. A chest x-ray is always performed after these procedures to make sure there were no complications from the biopsies, such as an accumulation of air in the chest (pneumothorax). The chest x-ray is also very important to see whether the majority of the fluid has been removed and if the lung is now able to expand with air and fill the chest cavity as it normally should. <strong>Mesothelioma Lawyers</strong></p>
<p>For more information on <strong>Mesothelioma Lawyers</strong> follow us on our RSS Feeds.</p>
<p>More-invasive testing may be needed if the initial results of the semi-invasive tests do not provide ade­quate information or if the CT scan indicates that it would be difficult to do the semi-invasive tests. The latter situation would occur if the fluid is not free flow­ing but is hidden in pockets that are difficult to reach. In such cases, it is better to inspect the chest directly to find out where to do the biopsy. A thoracoscopy (the use of a lighted scope, with or without a camera, to look into the chest) is performed in patients who are at risk for mesothelioma and who develop a large fluid accumulation, with or without associated solid tumor masses in the chest. In patients who are at risk for mesothelioma but whose thoracentesis does not reveal cancer cells, or who experience a recurrence of fluid after the initial thoracentesis is performed, a thora­coscopy should probably be performed. This procedure involves using a special lighted instrument called a thoracoscope to look inside the chest cavity. The scope is placed into the chest between two ribs after a small (1-inch) cut is made through the chest wall. If the doctor finds any tissue that looks abnormal, he or she will cut out a piece, or biopsy a piece, of it to have it looked at under the microscope. This tissue will then be examined for cancer cells. <strong>Mesothelioma Lawyers</strong></p>
<p>Information from other sources on <strong>Mesothelioma Lawyers</strong></p>
<p>Lastly, if the radiologic tests indicate that there is more solid tumor than fluid, or if there is no longer a space where fluid can accumulate because of previous attempts to control the fluid, an &#8220;open” biopsy may be indicated. The incision does not have to be large if the pleura is thickened, but the procedure should be per­formed by a thoracic surgeon who understands the principles of mesothelioma treatment. This surgeon will usually suggest a 3- or 4-inch incision on the side of the chest, overlying an area of pleura that is thickened. The surgeon may or may not remove a small piece of rib at this site to allow a direct view of the thickened pleura. Many times, a good-sized piece of pleura (1 to 1 1/2 inches in diameter) can be removed at this site. Getting a quick freeze of the tis­sue in the operating room, with the pathologist look­ing at the biopsy, will ensure that there’s enough tissue to perform all the required testing and to make a diagnosis. Surgeons performing these biopsies should pick the right place for the biopsy, and the cut (inci­sion) for this biopsy should be in line with the longer incision that would be used later if the patient is a surgical candidate. That way, this shorter incision can be removed.</p>
<p>Our use of the term or terms <strong>Mesothelioma Lawyers</strong> is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.</p>
<p>To keep up to date on <strong>Mesothelioma Lawyers</strong> visit our site often.</p>
<p><strong>Mesothelioma Lawyers</strong></p>
]]></content:encoded>
			<wfw:commentRss>http://www.the-mesothelioma.net/mesothelioma-lawyers-information/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Actos Warning Breaking News</title>
		<link>http://www.the-mesothelioma.net/actos-warning-breaking-news/</link>
		<comments>http://www.the-mesothelioma.net/actos-warning-breaking-news/#comments</comments>
		<pubDate>Thu, 26 Jan 2012 16:36:39 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[The Mesothelioma]]></category>
		<category><![CDATA[Actos Warning]]></category>

		<guid isPermaLink="false">http://www.the-mesothelioma.net/?p=485</guid>
		<description><![CDATA[Actos Warning : One study of municipal distribution of BC in Spain detected 34,281 BC deaths registered between 1989 and 1998. They could observe that determinate zones exhibited a higher risk than others, these being provinces of Cadiz, Seville, Huelva, Barcelona, and Almeria. The municipal mortality patterns suggested that the industrial and mining activity in [...]]]></description>
			<content:encoded><![CDATA[<p><a title="Actos Warning" href="http://www.actos-attorneys.com/actos-warning/">Actos Warning</a> : One study of municipal distribution of BC in Spain detected 34,281 BC deaths registered between 1989 and 1998. They could observe that determinate zones exhibited a higher risk than others, these being provinces of Cadiz, Seville, Huelva, Barcelona, and Almeria. The municipal mortality patterns suggested that the industrial and mining activity in the Provinces of Seville and Huelva could be associated with higher BC mortality in these provinces. The mortality pattern assessed in two different areas of the Province of Barcelona, which is only observable in women, might be related to the textile industry traditionally situated in these areas (Lopez-Abente et al. <a title="Current Document" href="#bookmark65">2006</a>).The trend to decrease BC due to occupational exposure was reported in a pooled analysis of 11 case-control studies on BC conducted in European countries between 1976 and 1996. This analysis included 3346 male cases and 6840 male controls. Thirty-one occupations showed increase risk for BC and these occupations were grouped as metal workers, textile workers, painters, miners, and transport opera­tors. Higher odd ratios were observed on those people with duration of employment more than 25 years. However, the author concluded that the ratio of BCs caused by occupational exposure was lower than those identified one year ago and that the exposure to occupational carcinogens had been reduced in the European Union.</p>
<p>&nbsp;</p>
<p>More information on <strong>Actos Warning</strong></p>
<p>This would likely be due to the improvement in working conditions and the reduction of exposure, particularly, to aromatic amines in work. Currently, employ­ments that relate more to BC risk are those in metal sector, machinists, transport operators, and miners (Kogevinas et al. <a title="Current Document" href="#bookmark56">2003</a>).In addition to the analysis on men, a pooled analysis of 11 case-control studies in BC conducted in Western Europe showed that the rates of BC due to occupa­tional exposure had been reduced in women, with only a 8% of BC in women attributable to occupational carcinogens (Mannetje et al.<a title="Current Document" href="#bookmark66"> 1999</a>). Although in devel­oped countries strict regulatory controls may have contributed to a decreased bur­den of exposure to bladder carcinogens in the workplace, the situation is less apparent in developing countries.</p>
<p>Information from other sources on <strong>Actos Warning</strong></p>
<p>As in BC, in general, occupational case is more frequent in men than in women, although, an increased risk among women has been documented in several studies, including those employed in the rubber industry and, more recently, in healthcare settings. In a case-control study conducted in Iowa, female teachers, domestic ser­vice employees, and workers in laundering and dry-cleaning business had elevated risk of BC. Other gender and racial differences had been documented in occupa­tional BC. In this way, in a recent mortality study in the United States, the mortality ratios for AA men and women and Latino males in various occupations were found to be increased compared with workers of the same gender and ethnic-racial group (Delclos and Lerner <a title="Current Document" href="#bookmark34">2008</a>).</p>
<p>&nbsp;</p>
<p>Our use of the term or terms <strong>Actos Warning</strong> is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.</p>
<p>To keep up to date on <strong>Actos Warning</strong> visit our site often.</p>
<p>http://www.seedol.com</p>
]]></content:encoded>
			<wfw:commentRss>http://www.the-mesothelioma.net/actos-warning-breaking-news/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Actos and Bladder Cancer News Flash</title>
		<link>http://www.the-mesothelioma.net/actos-and-bladder-cancer-news-flash/</link>
		<comments>http://www.the-mesothelioma.net/actos-and-bladder-cancer-news-flash/#comments</comments>
		<pubDate>Thu, 26 Jan 2012 16:21:04 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[The Mesothelioma]]></category>
		<category><![CDATA[Actos and Bladder Cancer]]></category>

		<guid isPermaLink="false">http://www.the-mesothelioma.net/?p=483</guid>
		<description><![CDATA[Actos and Bladder Cancer : Bladder cancer treatment can include surgery, chemotherapy, radiation therapy, and immunotherapy. Although some of these treatments are used alone, often a combination of several treatments (i.e., both chemotherapy and surgery) is used for the most success. Selection of the most appropriate treatment is based on clinical staging, including pathological and [...]]]></description>
			<content:encoded><![CDATA[<p><strong><a title="Actos and Bladder Cancer" href="http://www.actosbladdercancerlawsuits.info/">Actos and Bladder Cancer</a> </strong> : Bladder cancer treatment can include surgery, chemotherapy, radiation therapy, and immunotherapy. Although some of these treatments are used alone, often a combination of several treatments (i.e., both chemotherapy and surgery) is used for the most success. Selection of the most appropriate treatment is based on clinical staging, including pathological and ra­diographic information, and individual preference in close consultation with your physician. When choosing a blad­der cancer treatment, it is important that you consider not only the potential for cancer cure but also the side effects and quality of life impact of various treatments.</p>
<p>More information on <strong>Actos and Bladder Cancer </strong></p>
<p>SURGICAL TREATMENT</p>
<p>Surgery plays an important role in both the staging and subsequent treatment of bladder cancer. Transurethral resection of a bladder tumor (TURBT) is the initial treat­ment step in the vast majority of patients with bladder cancer. TURBT provides valuable staging information, and pathological results from these procedures are used to make further decisions regarding what, if any, addi­tional therapy is needed. The gold standard treatment for muscle-invasive bladder cancer is radical cystectomy (removal of the bladder). Advances in surgical technique and anesthesia have reduced the complications associated with this procedure in the last two decades. The develop­ment of continent urinary diversion, which allows one to empty the bladder through the urethra, is an option for certain patients. Minimally invasive procedures such as laparoscopic or robotic-assisted radical cystectomy may also be treatment options. In addition, bladder-sparing procedures (either with partial removal of the bladder or aggressive TURBT frequently in combination with che­motherapy and/or radiation therapy) have allowed some patients to treat their cancer while leaving their blad­ders intact. Advances in surgical techniques continue to this day with the development of minimally invasive approaches to cystectomy. Both robotic-assisted and lapa­roscopic radical cystectomy have been performed safely in highly specialized centers and have the potential for decreased morbidity and a shorter period of recovery, but longer term follow-up is needed to determine if these pro­cedures are equivalent to open surgical techniques.</p>
<p>&nbsp;</p>
<p>Information from other sources on <strong>Actos and Bladder Cancer </strong></p>
<p>TURBT is often the first procedure you will have once diagnosed with a bladder tumor. This surgery is typically performed under general or spinal anesthesia as an out­patient procedure and without any incision, endoscopically through the urethra, which means a cystoscope is placed through the urethra and into the bladder. Through this scope your urologist can see the inside of your bladder and has the ability to resect, or remove, tumors in the bladder under direct vision using electrocautery. The electrocautery is also used to control bleeding after the resection is com­pleted. TURBT is extremely important for the staging of bladder tumors but can also be therapeutic for lower stage bladder cancers. Once the tumor has been removed, it can be analyzed under the microscope by a pathologist. The pathological findings dictate further treatment decisions. If the tumor is low grade and noninvasive, you will likely not need any further therapy at this point except for close follow-up.</p>
<p>&nbsp;</p>
<p>Our use of the term or terms <strong>Actos and Bladder Cancer </strong> is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.</p>
<p>To keep up to date on <strong>Actos and Bladder Cancer </strong> visit our site often.</p>
<p><strong>Actos and Bladder Cancer</strong></p>
]]></content:encoded>
			<wfw:commentRss>http://www.the-mesothelioma.net/actos-and-bladder-cancer-news-flash/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

<!-- Performance optimized by W3 Total Cache. Learn more: http://www.w3-edge.com/wordpress-plugins/

Page Caching using memcached
Database Caching 2/6 queries in 0.007 seconds using memcached
Object Caching 526/528 objects using memcached

Served from: www.the-mesothelioma.net @ 2012-02-08 14:26:19 -->
